In DLBCL, PRMT5 expression can be induced upon stimulation of the B-cell receptor (BCR) and downstream signaling pathway, while the overexpression of PRMT5 activates PI3K-AKT signaling creating a positive feedback loop to promote cell cycle progression and survival [36]. Here, PRMT5 is linked to diffuse large B-cell lymphoma.